You are in the accessibility menu

Statistics

Total Visits

Views
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 86

Total Visits per Month

May 2024 June 2024 July 2024 August 2024 September 2024 October 2024 November 2024
The results of a randomized trial looking at 24 weeks vs 48 weeks of treatment with peginterferon alpha-2a (40 kDa) and ribavirin combination therapy in patients with chronic hepatitis C genotype 1 0 1 0 1 1 0 0

File Downloads

Views

Top Country Views

Views
United States 43
Germany 23
China 8
Russia 5
Ukraine 5
France 1
Vietnam 1

Top City Views

Views
Ashburn 17
Cambridge 6
Fairfield 6
Jacksonville 5
Seattle 3
Nanjing 2
Yang 2
Brooklyn 1
Changsha 1
Hanoi 1